Net income surged nearly 60% year-over-year to $2.5 million.
Rental income grew 5.2% while property operating expenses grew only 4.5%.
Expiration of $75M in interest rate swaps increased floating rate exposure.
Definitive acquisition pipeline of $99 million for 2026-2027.
The Q1 2026 filing reveals a company at a crossroads between aggressive expansion and tightening financial constraints. While the surge in net income and the growth in rental revenue suggest a strong operational core, the reliance on a revolving credit facility to fund a $28.5 million acquisition in the quarter highlights a dependence on debt for growth. The transition of $75 million in debt from fixed to floating rates introduces a new layer of volatility to the income statement. Ultimately, the investment thesis hinges on whether CHCT can successfully close its pending $99 million pipeline and maintain occupancy levels without further eroding its cash cushion. The tension between a high dividend payout and the need for capital expenditures for redevelopment projects will be the primary driver of valuation in the coming quarters. Investors must weigh the ability to compound value through healthcare specialization against the risks of floating-rate debt and tenant credit deterioration.